Wynands JE. The role of amrinone in treating heart failure during and after coronary artery surgery supported by cardiopulmonary bypass. J Card Surg. 1994 May;9(3 Suppl):453-8.
McGhie AI, Golstein RA. Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy. Chest. 1992 Nov;102(5 Suppl 2):626S-632S.
Hauptman PJ, Kelly RA. Digitalis. Circulation. 1999 Mar 9;99(9):1265-70.
Downing SW, Edmunds LH Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992 Dec;54(6):1236-43. 1340777
Graeber GM. Tamim W. Current status of the diagnosis and treatment of thymoma. Semin Thorac Cardiovasc Surg. 12(4):268-77, 2000 Oct.
Greenberg BH. Role of angiotensin receptor blockers in heart failure: not yet RESOLVD. Circulation. 1999 Sep 7;100(10):1032-4.
Cohn JN. The management of chronic heart failure. N Engl J Med. 1996 Aug 15;335(7):490-8.
Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation. 1995 Nov 15;92(10):3132-7.
Bristow MR. beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000 Feb 8;101(5):558-69.
Constant J. A review of why and how we may use beta-blockers in congestive heart failure. Chest. 1998 Mar;113(3):800-8.
Merin RG. Basic physiology and pharmacology of cardiovascular function. Journal of Cardiac Surgery 1990 5(3 Suppl):266-71
Chapters 96 and 99: Cardiovascular Function and Physiology; Pharmacologic Approach to the Management of the Cardiac Surgical Patient. Glenn's Thoracic and Cardiovascular Surgery (Baue, Geha, Hammond, Laks, and Naunheim), 6th ed., 1549-1560, 1599-1616.